Lee Rauch

Ms. Rauch is a Senior Executive and Business Advisor to public and venture backed life science companies with over 25 years of experience, including serving as CEO and in C-level positions. She is currently an Entrepreneur in Residence (EIR) at Fortress Biotech. As EIR, she identifies acquisition or investment opportunities through her relationships with leading scientists, physicians and founders at universities, early stage biotech companies and foreign pharma companies.  Previously, she was Chief Business Officer of Global Blood Therapeutics (GBT), a Third Rock Venture start up that is currently a multi-billion-dollar public company. At GBT, she helped grow the company from a few scientists doing molecular modeling to an integrated, multi-disciplinary organization with a potential block buster product in clinical development. Prior to GBT, Ms. Rauch was President and CEO of Nuon Therapeutics, a venture backed, clinical development stage company focused on inflammatory and rheumatic diseases. Ms. Rauch also held senior-level positions as Chief Business Officer at Onyx Pharmaceuticals (acquired by Amgen), SVP Corporate Development at COR Therapeutics (now part of Takeda) and Vice President of Strategic Marketing at Syntex (acquired by Hoffmann-La Roche).

Ms. Rauch’s consulting experience covers serving as managing director for Cervantes Life Science Partners and heading the Life Science Practice as a partner at the Mitchell Madison Group (acquired by US Web). She repositioned companies facing critical strategic and operational crossroads and executed successful business development, financing and M&A transactions. Her clients included Viralytics (acquired by Merck), Afferent Pharmaceuticals (acquired by Merck) and Stryker, where she worked on the multi-billion-dollar merger with Pfizer’s Howmedica Division. She was also a founding member of McKinsey & Company’s multinational pharmaceutical practice.

 Ms. Rauch is an active member of the Healthcare Business Women’s Association and a Springboard Enterprises Life Science Advisor. Previously, she was an expert advisor to several California Life Science Fellows All Star Team start-ups. Three of her companies have been funded and one is now public.  Ms. Rauch earned her undergraduate degree in chemistry from Arizona State University and her MBA degree from the University of Chicago.

Ms. Rauch has experience in several therapeutic areas including oncology, cardiovascular diseases, chronic cough, autoimmune diseases, CNS disorders and orphan drugs. She worked on the approved drugs Kyprolis®, Nexavar®, INTEGRILIN, CellCept®, Cytovene® and Aloxi®.